Published in Health and Medicine Week, December 4th, 2006
This trend article about Seoul National University, South Korea, is an immediate alert from NewsRx to identify developing directions of research.
Y. Ilkim and colleagues, Seoul National University, wrote that the study was done "to evaluate the feasibility of an iodized oil emulsion that is used for the chemoembolization of hepatocellular carcinoma as a modifier...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.